NASDAQ
SVRA

Savara Inc

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Savara Inc Stock Price

Vitals

Today's Low:
$3.71
Today's High:
$3.83
Open Price:
$3.79
52W Low:
$1.08
52W High:
$4.21
Prev. Close:
$3.81
Volume:
282041

Company Statistics

Market Cap.:
$515.01 million
Book Value:
0.768
Revenue TTM:
$1000
Operating Margin TTM:
0%
Gross Profit TTM:
$-28991000
Profit Margin:
0%
Return on Assets TTM:
-20.31%
Return on Equity TTM:
-39.75%

Company Profile

Savara Inc had its IPO on 2017-06-01 under the ticker symbol SVRA.

The company operates in the Healthcare sector and Biotechnology industry. Savara Inc has a staff strength of 28 employees.

Stock update

Shares of Savara Inc opened at $3.79 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.71 - $3.83, and closed at $3.75.

This is a -1.57% slip from the previous day's closing price.

A total volume of 282,041 shares were traded at the close of the day’s session.

In the last one week, shares of Savara Inc have slipped by -2.34%.

Savara Inc's Key Ratios

Savara Inc has a market cap of $515.01 million, indicating a price to book ratio of 1.4682 and a price to sales ratio of 131146.

In the last 12-months Savara Inc’s revenue was $1000 with a gross profit of $-28991000 and an EBITDA of $-44909000. The EBITDA ratio measures Savara Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Savara Inc’s operating margin was 0% while its return on assets stood at -20.31% with a return of equity of -39.75%.

In Q2, Savara Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Savara Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-0.27 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Savara Inc’s profitability.

Savara Inc stock is trading at a EV to sales ratio of 11.9082 and a EV to EBITDA ratio of -1.6744. Its price to sales ratio in the trailing 12-months stood at 131146.

Savara Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$119.83 million
Total Liabilities
$5.89 million
Operating Cash Flow
$0
Capital Expenditure
$225000
Dividend Payout Ratio
0%

Savara Inc ended 2024 with $119.83 million in total assets and $0 in total liabilities. Its intangible assets were valued at $119.83 million while shareholder equity stood at $87.72 million.

Savara Inc ended 2024 with $0 in deferred long-term liabilities, $5.89 million in other current liabilities, 116000.00 in common stock, $-360671000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $22.75 million and cash and short-term investments were $105.18 million. The company’s total short-term debt was $67,000 while long-term debt stood at $26.21 million.

Savara Inc’s total current assets stands at $107.90 million while long-term investments were $0 and short-term investments were $82.43 million. Its net receivables were $1.00 million compared to accounts payable of $2.50 million and inventory worth $1.56 million.

In 2024, Savara Inc's operating cash flow was $0 while its capital expenditure stood at $225000.

Comparatively, Savara Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$3.75
52-Week High
$4.21
52-Week Low
$1.08
Analyst Target Price
$5.5

Savara Inc stock is currently trading at $3.75 per share. It touched a 52-week high of $4.21 and a 52-week low of $4.21. Analysts tracking the stock have a 12-month average target price of $5.5.

Its 50-day moving average was $3.52 and 200-day moving average was $2.51 The short ratio stood at 4.43 indicating a short percent outstanding of 0%.

Around 196.1% of the company’s stock are held by insiders while 5882.7% are held by institutions.

Frequently Asked Questions About Savara Inc

The stock symbol (also called stock or share ticker) of Savara Inc is SVRA

The IPO of Savara Inc took place on 2017-06-01

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
$482.25
-25.35
-4.99%
Tips Films Ltd (TIPSFILMS)
$528
-7.5
-1.4%
$30.25
0.3
+1%
$5.5
-0.08
-1.43%
$606.55
-16
-2.57%
$117.1
7.46
+6.8%
Sylvamo Corp (SLVM)
$41.38
0.57
+1.4%
$119.1
-19.6
-14.13%
$995.5
-63.35
-5.98%
$3.55
0.1
+2.9%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company’s lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Austin, Texas.

Address

Building III, Austin, TX, United States, 78746